Physician profile
Bryan Matino Pham
NPI 1154702033
$11,826.87
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,343 · 2020: $360 · 2021: $319 · 2022: $987 · 2023: $732 · 2024: $8,086.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,000 · Travel and Lodging: $3,137 · Food and Beverage: $681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,000.00 |
| Travel and Lodging | $3,136.95 |
| Food and Beverage | $680.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $8,062.24 | 2020-2024 | Saffron |
| Boston Scientific Corporation | $1,375.71 | 2019-2023 | |
| Teleflex LLC | $778.62 | 2021-2022 | |
| Palette Life Sciences, INC. | $635.80 | 2023 | |
| Astellas Pharma US INC | $175.72 | 2019-2021 | |
| Abbott Laboratories | $148.40 | 2022 | |
| Neotract INC. | $146.85 | 2020 | |
| Janssen Scientific Affairs, LLC | $99.13 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $71.01 | 2021 | |
| Eisai INC. | $66.80 | 2020-2021 | |
| Endo Pharmaceuticals INC. | $56.22 | 2021 | |
| Procept Biorobotics Corporation | $46.16 | 2022-2023 | Aquabeam Robotic System |
| Checkpoint Surgical, INC | $40.75 | 2024 | Checkpoint Stimulators |
| Laborie Medical Technologies Corp. | $25.18 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| 180 Medical, INC. | $21.37 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hollister Incorporated | $21.30 | 2020 | |
| Janssen Biotech, INC. | $19.73 | 2024 | Erleada |
| Exelixis INC. | $18.29 | 2024 | Cabometyx |
| Olympus America INC. | $17.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.